Posted on February 23, 2021
By Mahender Nayak | Takeda, Senior VP/Head of ICMEA Region (India, Turkey, CIS countries, Middle East and Africa)
January 18, 2021
By Michaela Hrdlickova | Biogen, Director Patient Advocacy Europe/Canada/Partner Markets, SMA
I have been involved in the pharmaceutical industry since 1995. Between 2010–2017, I was Country Director of Biogen, Czech Republic. Since 2011 I have held position the of Vice President of the Association of Innovative Pharmaceutical Industry. In 2017-2019, I led the international team responsible for a specific therapeutic area in Central/Eastern Europe. Currently, I […]
January 25, 2021
By Agnes Ho | Roche Diagnostics, Head of Sub-Region Two, Developed Growth Markets, Asia Pacific
January 27, 2021
By Soo Bang | Bristol-Myers Squibb, Vice president, Enterprise Integration Lead
January 13, 2021
By Anand Narasimhan | Merck Specialties Pvt LTD, Managing Director
January 20, 2021
By Brigid Waite | Roche, Deputy Medical Director – Strategic Partner Chapter Lead, Medical Affairs
December 23, 2020
By Eva McLellan | Roche, Head of Business Strategy, Transformation & Innovation, Belgium
January 4, 2021
By Antonio Bebba | Pfizer, Diversity & Inclusion Council Europe Member
January 6, 2021
By Teri Lawver | Janssen Pharmaceuticals, Global Vice President, Immunology, Global Commercial Strategy Leader
February 3, 2021
By Susan King-Barnardo | Merck Group, Manging Director – Greece
December 21, 2020
By Jonathan Scott | Eli Lilly, Digital Strategy Manager, Corporate Affairs and Communications & Chair Emeritus of the Lilly Pride employee resource group
February 1, 2021
By Emmanuelle Quiles | Janssen, Europe, Middle East & Africa, President France
February 8, 2021
By Jörg Rupp | Roche, Head of Roche Pharma International (I7)
February 10, 2021
By Fernando Borras | Takeda, Business Operations Head Middle East
